+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes



High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes



Bmc Cancer 16: 350



Early detection of oral squamous cell carcinomas (OSCCs) is urgently needed to improve the prognosis and quality of life (QOL) of patients. Oral leukoplakias (OLs), known as the most common premalignant lesions in the oral cavity, often precede OSCCs. Especially, OLs with dysplasia are known to have a high risk of malignant transformation. Here, we searched for the promoter methylation characteristic of high-risk OLs. To identify methylation-silenced genes, a combined analysis of methylated DNA immunoprecipitation (MeDIP) - CpG island (CGI) microarray analysis and expression microarray analysis after treatment with a demethylating agent was performed in two OSCC cell lines (Ca9-22 and HSC-2). The methylation statuses of each gene were examined by methylation-specific PCR. A total of 52 genes were identified as candidates for methylation-silenced genes in Ca9-22 or HSC-2. The promoter regions of 13 genes among the 15 genes randomly selected for further analysis were confirmed to be methylated in one or more of five cell lines. In OSCC tissues (n = 26), 8 of the 13 genes, TSPYL5, EGFLAM, CLDN11, NKX2-3, RBP4, CMTM3, TRPC4, and MAP6, were methylated. In OL tissues (n = 24), seven of the eight genes, except for EGFLAM, were found to be methylated in their promoter regions. There were significantly greater numbers of methylated genes in OLs with dysplasia than in those without dysplasia (p < 0.0001). OLs at high risk for malignant transformation were associated with aberrant promoter methylation of multiple genes.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057995154

Download citation: RISBibTeXText

PMID: 27255271

DOI: 10.1186/s12885-016-2371-5


Related references

Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas. Cancer Genetics & Cytogenetics 144(2): 134-142, July 15, 2003

Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer. Cancer Epidemiology, Biomarkers and Prevention 17(10): 2786-2794, 2008

Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Research 61(1): 249-255, 2001

Aberrant promoter methylation of multiple genes during multistep pathogenesis of colorectal cancers. International Journal of Cancer 118(4): 924-931, 2005

Aberrant methylation in promoter-associated CpG islands of multiple genes in therapy-related leukemia. International Journal of Oncology 23(3): 693-696, 2003

Aberrant methylation in promoter-associated CpG islands of multiple genes in acute lymphoblastic leukemia. Leukemia Research 30(1): 98-102, 2005

Aberrant promoter methylation of multiple genes in bronchoalveolar lavage DNA of patients with lung cancer. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1163, 2003

Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia. Haematologica 89(2): 154-164, 2004

Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. Cancer Research 62(2): 351-355, 2002

Aberrant methylation in promoter-associated CpG islands of multiple genes in chronic myelogenous leukemia blast crisis. Oncology Letters 3(1): 190-192, 2012

Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia. Oncology Reports 12(1): 97-99, 2004

Aberrant promoter methylation of p15 (INK⁴b) and p16 (INK⁴a) genes may contribute to the pathogenesis of multiple myeloma: a meta-analysis. Tumour Biology 35(9): 9035-9043, 2014

Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. Clinical Cancer Research 8(10): 3164-3171, 2002

Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes. Cancer Research 64(11): 3757-3760, 2004

Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area. Molecular and Cellular Biochemistry 332(1-2): 51-58, 2010